ES2085567T3 - Composiciones nutritivas, farmaceuticas y cosmeticas que contienen di-linoleoil-mono-gamma-linolenil-glicerol. - Google Patents

Composiciones nutritivas, farmaceuticas y cosmeticas que contienen di-linoleoil-mono-gamma-linolenil-glicerol.

Info

Publication number
ES2085567T3
ES2085567T3 ES92304820T ES92304820T ES2085567T3 ES 2085567 T3 ES2085567 T3 ES 2085567T3 ES 92304820 T ES92304820 T ES 92304820T ES 92304820 T ES92304820 T ES 92304820T ES 2085567 T3 ES2085567 T3 ES 2085567T3
Authority
ES
Spain
Prior art keywords
glycerol
gamma
mono
linolenil
linoleoil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92304820T
Other languages
English (en)
Inventor
David F Horrobin
Yung-Sheng Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of ES2085567T3 publication Critical patent/ES2085567T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Logic Circuits (AREA)
  • Detergent Compositions (AREA)
  • Edible Oils And Fats (AREA)
  • Amplifiers (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTA UN GLICEROL SINTETICO O NATURAL QUE COMPRENDE AL MENOS EL 20%, Y PREFERIBLEMENTE EL 25% DE DI-LINOLEOIL-MONOGAMMA-LINOLENIL-GLICEROL (DLMG), QUE SE USA PARA ALIMENTOS SUPLEMENTARIOS, COMPOSICIONES NUTRICIONALES Y COMPUESTOS PARA EL CUIDADO DE LA PIEL Y DEL CABELLO.
ES92304820T 1991-06-03 1992-05-28 Composiciones nutritivas, farmaceuticas y cosmeticas que contienen di-linoleoil-mono-gamma-linolenil-glicerol. Expired - Lifetime ES2085567T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (1)

Publication Number Publication Date
ES2085567T3 true ES2085567T3 (es) 1996-06-01

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92304820T Expired - Lifetime ES2085567T3 (es) 1991-06-03 1992-05-28 Composiciones nutritivas, farmaceuticas y cosmeticas que contienen di-linoleoil-mono-gamma-linolenil-glicerol.

Country Status (20)

Country Link
US (4) US5328691A (es)
EP (1) EP0520624B1 (es)
JP (1) JP2704922B2 (es)
KR (2) KR100274727B1 (es)
AT (1) ATE136214T1 (es)
AU (1) AU652827B2 (es)
CA (1) CA2069600C (es)
DE (1) DE69209571T2 (es)
DK (1) DK0520624T3 (es)
ES (1) ES2085567T3 (es)
FI (1) FI103867B1 (es)
GB (1) GB9111900D0 (es)
GR (1) GR3019840T3 (es)
HK (1) HK4597A (es)
IE (1) IE75224B1 (es)
NO (1) NO180804C (es)
NZ (1) NZ242898A (es)
SG (1) SG49739A1 (es)
TW (1) TW288975B (es)
ZA (1) ZA923913B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
EP0707850A1 (en) * 1994-09-21 1996-04-24 Scotia Holdings Plc Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
EP2251410A3 (en) * 1996-03-28 2011-09-28 DSM IP Assets B.V. Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
CA2250575C (en) * 1996-03-28 2007-07-24 Gist-Brocades B.V. Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
IL133902A0 (en) * 1997-07-16 2001-04-30 Impulse Dynamics Ltd Smooth muscle controller
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
CA2417552C (en) * 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
DK3111767T3 (da) 2002-06-19 2019-08-26 Dsm Ip Assets Bv Mikrobiel olie og fremgangsmåder til forarbejdning deraf
AU2003255863A1 (en) * 2002-07-31 2004-02-23 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
KR100975793B1 (ko) 2002-10-23 2010-08-16 에이제토 엘렉토로닉 마티리알즈 가부시키가이샤 화학 증폭 포지티브형 감광성 수지 조성물
WO2004068970A2 (en) * 2003-01-31 2004-08-19 The Procter & Gamble Company Means for improving the appearance of mammalian keratinous tissue
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US10017453B2 (en) 2013-11-15 2018-07-10 Ds Biopharma Limited Pharmaceutically acceptable salts of fatty acids
KR102391827B1 (ko) 2014-06-04 2022-04-27 디에스 바이오파마 리미티드 Dgla를 포함하는 약제학적 조성물 및 그의 용도
CN107666904B (zh) 2015-03-26 2022-02-01 提贝托·布鲁泽塞 多不饱和脂肪酸的纯化组合物、其制备方法及其用途
CN113896628A (zh) 2015-05-13 2022-01-07 Ds生物制药有限公司 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
DE3368377D1 (en) * 1982-04-16 1987-01-29 Nestle Sa Lipid composition for oral, enteral or parenteral feeding
DE3366530D1 (en) * 1982-04-29 1986-11-06 Efamol Ltd Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
SG49739A1 (en) 1998-06-15
FI103867B (fi) 1999-10-15
HK4597A (en) 1997-01-17
CA2069600C (en) 2004-05-04
JPH05201924A (ja) 1993-08-10
US5614208A (en) 1997-03-25
TW288975B (es) 1996-10-21
EP0520624A1 (en) 1992-12-30
JP2704922B2 (ja) 1998-01-26
GR3019840T3 (en) 1996-08-31
KR100274727B1 (ko) 2000-12-15
ZA923913B (en) 1993-02-24
FI922542A0 (fi) 1992-06-02
NZ242898A (en) 1994-12-22
ATE136214T1 (de) 1996-04-15
CA2069600A1 (en) 1992-12-04
NO180804C (no) 1997-07-02
KR100277424B1 (ko) 2000-12-15
DE69209571T2 (de) 1996-09-05
US5328691A (en) 1994-07-12
DK0520624T3 (da) 1996-05-06
NO922183D0 (no) 1992-06-02
AU1727892A (en) 1992-12-10
FI922542A (fi) 1992-12-04
KR930000664A (ko) 1993-01-15
GB9111900D0 (en) 1991-07-24
AU652827B2 (en) 1994-09-08
FI103867B1 (fi) 1999-10-15
US5552150A (en) 1996-09-03
IE75224B1 (en) 1997-08-27
EP0520624B1 (en) 1996-04-03
NO922183L (no) 1992-12-04
DE69209571D1 (de) 1996-05-09
US5620701A (en) 1997-04-15
NO180804B (no) 1997-03-24
IE921663A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
ES2085567T3 (es) Composiciones nutritivas, farmaceuticas y cosmeticas que contienen di-linoleoil-mono-gamma-linolenil-glicerol.
ES2056220T3 (es) Composicion cosmetica.
DE69617436D1 (de) Minoxidil enthaltendes haarpflegemittel mit einem niedrigen gehalt an fettigem lösungsmittel
DE60040096D1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
DK0631772T3 (da) Retinoidholdig sammensætning
ATE69550T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
ES2081888T3 (es) Proteccion contra la oxidacion de un producto alimenticio, cosmetico o farmaceutico.
IL96903A0 (en) Topical pharmaceutical compositions comprising a vitamin d3 derivative
MX7102E (es) Composicion cosmetica base para crema
DE69208865D1 (de) Haarpflegemittel
RO95866B1 (ro) Crema de fata cu biostimulatori pentru ten uscat
DE3761467D1 (de) Haarversorgungsmittel.
KR890012632A (ko) 향장 영양 조성물
HU214442B (hu) Regulátor és növénytápláló készítmény és eljárás annak a növénytermesztésben való alkalmazására

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 520624

Country of ref document: ES